CLINICAL_TRIALS
trial_result
· 2015-02-12
Clinical Trial Update: Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection [Phase 2]
Summary
Phase 2 trial update on VP20621 for prevention of recurrent Clostridium difficile infection has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Clostridium Difficile Infection | Phase 2 | Status: COMPLETED | Results posted: 2015-02-12